Yearly Archives - 2018

Start-Ups Set to Pitch at AgTech Nexus 2018

Agribusinesses, investors, and tech companies will gather next month to learn about innovations and investment opportunities in the ever-changing and exciting ag tech sector. Attendees of AgTech Nexus USA, which will be held in Boston on June 6 and 7, will gain market knowledge, understand the current trends impacting deal flow in ag tech, and learn from intriguing discussions led by industry leaders. KnipBio to participate. Read more >>
Read more...

The Unlocking of Vision

The eSight glasses are electronic glasses that have a high speed and high resolution camera in the middle of the frame that captures and collects everything a user looks at in real time. Even though the glasses are expensive, they allow people to see life from a different perspective. The glasses come with a remote control that allows the camera to zoom in. Read more >>
Read more...

Virtual Reality is a Failure … ? Probably Not.

Boston Harbor Angel members, Ziad Moukheiber and David Powsner, are the hosts of Failure – the Podcast, a podcast about about business failures, focusing on startups and emerging companies. Virtual reality, ... augmented reality, ... mixed reality, ... oh my! Is this just more hype from the tech industry, or is there really something to this? Grand View Research says that the market for virtual reality and alternative reality (VR/AR) was just under $1B in 2016 and predicts...
Read more...

Corbus Pharmaceuticals Adds Two Key Executives to Lead its Regulatory and CMC Operations

Corbus Pharmaceuticals Holdings, Inc., a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic and serious inflammatory and fibrotic diseases, announced today the appointment of Robert Discordia, Ph.D., as Vice President, Pharmaceutical Development & Manufacturing, and Ross Lobell as Vice President, Regulatory Affairs. Dr. Discordia will oversee all aspects of Corbus’ chemistry, manufacturing and controls (CMC) for lenabasum and future drug candidates. Mr. Lobell will lead Corbus’ Regulatory Affairs and Quality...
Read more...